Equitable Holdings’s UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share UPH.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-34,730
Closed -$417 1175
2023
Q3
$417 Hold
34,730
﹤0.01% 1067
2023
Q2
$691 Hold
34,730
﹤0.01% 1039
2023
Q1
$695 Hold
34,730
﹤0.01% 975
2022
Q4
$451 Hold
34,730
﹤0.01% 897
2022
Q3
$2K Hold
34,730
﹤0.01% 864
2022
Q2
$2K Buy
34,730
+9,000
+35% +$902 ﹤0.01% 852
2022
Q1
$5K Buy
+25,730
New +$7.93K ﹤0.01% 868

Other funds holding UPH.WS

Equitable Holdings's UPH.WS Position: Q4 2023 in Review

Equitable Holdings sold out of UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share (UPH.WS) in Q4 2023, closing a stake of 34,730 shares — an estimated $417 sold.

Equitable Holdings first reported a position in UPH.WS in Q1 2022 and held it in 7 quarters. The position peaked at $5K in Q1 2022. 1 fund tracked by Wall St. Rank holds UPH.WS as of Q4 2023.

  • Equitable Holdings reported no remaining UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position as of Q4 2023 after selling out during the quarter.
  • Equitable Holdings sold 34,730 UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share shares in Q4 2023, an estimated $417.
  • Equitable Holdings first reported a position in UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share in Q1 2022 and held it in 7 quarters.
  • Equitable Holdings's UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share position peaked at $5K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share as of Q4 2023.

Based on Equitable Holdings's 13F filing for Q4 2023, filed 13 Feb 2024.